High-density mapping validation of antral pulmonary vein isolation and posterior wall isolation created with a new cryoballoon ablation system: The first reported case.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
12 2020
Historique:
received: 26 08 2020
revised: 02 09 2020
accepted: 03 09 2020
pubmed: 10 9 2020
medline: 29 7 2021
entrez: 9 9 2020
Statut: ppublish

Résumé

Cryoballoon ablation is a recognized and widespread method for pulmonary vein isolation. For many years the impossibility of using it to create additional lines was considered a drawback of this approach. However, recently, the technique was adapted to allow the creation of rooflines, and potentially also inferior lines. In this article, we present the first reported case of a patient submitted to pulmonary vein isolation plus posterior wall isolation using the novel Boston POLAR X™ cryoballoon exclusively. To confirm the quality of the lesions, the patient underwent pre and postablation high-density mapping.

Identifiants

pubmed: 32905654
doi: 10.1111/jce.14741
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

3318-3321

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Kirchhof P, Benussi S, Kotecha D, et al. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-2962
Kuck KH, Fürnkranz A, Chun KRJ, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 2016;37(38):2858-2865.
Nishimura T, Yamauchi Y, Aoyagi H, et al. The clinical impact of the left atrial posterior wall lesion formation by the cryoballoon application for persistent atrial fibrillation: feasibility and clinical implications. J Cardiovasc Electrophysiol. 2019;30(6):805-814.

Auteurs

Massimo Moltrasio (M)

Heart Rhythm Center, Centro Cardiologico Monzino IRCCS, Milan, Italy.

Adriano N Kochi (AN)

Heart Rhythm Center, Centro Cardiologico Monzino IRCCS, Milan, Italy.

Gaetano Fassini (G)

Heart Rhythm Center, Centro Cardiologico Monzino IRCCS, Milan, Italy.

Stefania Riva (S)

Heart Rhythm Center, Centro Cardiologico Monzino IRCCS, Milan, Italy.

Fabrizio Tundo (F)

Heart Rhythm Center, Centro Cardiologico Monzino IRCCS, Milan, Italy.

Claudio Tondo (C)

Heart Rhythm Center, Centro Cardiologico Monzino IRCCS, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH